October 8, 1989
So the Senate has approved more money for the War on Drugs than the House, which has approved more money than President Bush proposed. And yet everyone agrees that the money won't do much at all to stop drug abuse. I suggest we do as we did in Vietnam: Let's declare a victory in the War on Drugs--in spite of the evidence to the contrary--and stop throwing our money away on a fight we can't win. BRENDA McGILL Oceanside
CALIFORNIA | LOCAL
August 16, 1996
It seems that every time I turn around The Times has another naive editorial about drug use in the music industry. Now The Times is suggesting that health Nazis report any drug use by artists within the industry (Aug. 13). I would suggest that the laws regarding drugs make the drugs much more dangerous than they would be on their own. Your editorial policy adds one very loud voice in keeping the underworld afloat and ensuring that potency of drugs remains a deadly guessing game. Human nature has always sought relief from anguish and pain.
CALIFORNIA | LOCAL
November 22, 1993
It seems that the legalization of drugs is an idea whose time has come. This is most evident by the increased support of legalization by the right wing. However, it seems that some of the right wing have a hard time understanding the dynamics that make drug prohibition a fruitless endeavor. Take, for example, Column Right by Paul Craig Roberts ("Drug Laws Aid and Abet Crime Wave," Nov. 14). Though the headline clearly implies a column on the merits of drug legalization, the reader soon discovers that Roberts instead largely delivers a diatribe opposed to gun control.
April 23, 2014 |
Two drugs given to people who suffer migraines reduced the frequency of their headaches in early trials, scientists said. The test results “may potentially represent a new era in preventive therapy for migraine,” Dr. Peter Goadsby, an author on studies of both drugs, said in a statement. One of the researchers called migraine headaches the third most common medical disorder in the world. Both drugs must undergo larger trials to confirm the results. Both drugs are intended to prevent rather than treat migraine headaches, and the studies of them are the first to test monoclonal antibodies for migraine prevention, the scientists said.